50 employees
AthGene is the world's first subscription-based genetics platform.
2015
$577K
from 2 investors over 2 rounds
AthGene raised $577K on March 16, 2017
Investors: SEED Capital Denmark
AthGene raised undisclosed on May 1, 2016
Investors: Kjøller